Workflow
巨子生物持续走弱,股价创年内新低,市场关注双十一可复美销情

Group 1 - The "Double Eleven" shopping festival for 2025 has quietly begun, with a focus on the cosmetics sector experiencing a weaker Q3 due to seasonal trends [1] - According to data from Chian Mama, some key brands have shown a decline in growth rates on Douyin in Q3, with Juzhi Biological's GMV increasing by 15% year-on-year, while Kefu Mei and Keli Jin saw increases of 5% and 78% respectively [1] - Juzhi Biological is expected to focus on boosting sales during the upcoming Double Eleven event in the second half of the year [1] Group 2 - Huaxi Biological has reported issues regarding the collagen products, stating that multiple third-party testing results indicated that the added amount of recombinant collagen in related products did not meet standards [2] - Huaxi Biological has submitted dozens of test reports to the National Medical Products Administration [2]